Table 1.
Type of fistula | Sex (Male/female) | Age (yr) | Time of evolution (d) | Fistula output (mL/24 h) | Fistula closure time (d) | Restart oral intake (d) |
Esophago-gastrocutaneous | ||||||
Study group (n = 3) | 3/0 | 48.6 ± 12.2 | 23.3 ± 7 | 70 ± 42.7 | 8 ± 4 | 12 ± 3.6 |
Control group (n = 7) | 7/0 | 49.1 ± 10.5 | 18.8 ± 4.4 | 88.1 ± 19 | 19.1 ± 6 | 24 ± 8.6 |
1P value | P = 0.85 | P = 0.24 | P = 0.15 | P < 0.05 | P < 0.05 | |
Gastrocutaneous | ||||||
Study group (n = 5) | 4/1 | 58.6 ± 9.4 | 93.8 ± 85.1 | 151.4 ± 146.1 | 7 ± 3.1 | 9.8 ± 2.4 |
Control group (n = 10) | 6/4 | 47.4 ± 16.7 | 86.6 ± 69.8 | 131.4 ± 28.8 | 35.2 ± 18.7 | 39.7 ± 20.1 |
1P value | P = 0.19 | P = 0.86 | P = 0.67 | P < 0.01 | P < 0.01 | |
Duodeno-jejunocutaneuos | ||||||
Study group (n = 5) | 2/3 | 38.2 ± 10.4 | 25.6 ± 4.9 | 111.6 ± 75.9 | 7.6 ± 2.6 | 11.6 ± 4.3 |
Control group (n = 10) | 6/4 | 44.1 ± 11.2 | 22.8 ± 4.2 | 123.6 ± 19.9 | 30 ± 17.1 | 34.9 ± 17.2 |
1P value | P = 0.34 | P = 0.27 | P = 0.63 | P < 0.01 | P < 0.01 | |
Ileocutaneous | ||||||
Study group (n = 6) | 2/4 | 53.1 ± 5 | 28.1 ± 9.6 | 132.8 ± 47.6 | 16.1 ± 21.6 | 18.3 ± 20.6 |
Control group (n =12) | 6/6 | 55.4 ± 13.1 | 23 ± 4.7 | 143 ± 36 | 37.8 ± 17.2 | 42.5 ± 17.7 |
1P value | P = 0.69 | P = 0.13 | P = 0.61 | P < 0.05 | P < 0.05 | |
Colocutaneous | ||||||
Study group (n = 4) | 3/1 | 61.5 ± 8.3 | 40.2 ± 17 | 87.7 ± 40.8 | 23.5 ± 19.5 | 25 ± 17.8 |
Control group (n = 8) | 5/3 | 60.1 ± 11.9 | 33.1 ± 13.2 | 106.1 ± 16.5 | 36.2 ± 22.8 | 40 ± 23.1 |
1P value | P = 0.84 | P = 0.44 | P = 0.28 | P = 0.36 | P = 0.25 | |
All types of enterocutaneous fistulas | ||||||
Study group (n = 23) | 14/9 | 51.9 ± 11.6 | 43.3 ± 46.3 | 116.2 ± 81.5 | 12.5 ± 14.2 | 15.3 ± 13.3 |
Control group (n = 70) | 30/17 | 51.1 ± 13.7 | 37.5 ± 40.9 | 121.9 ± 31.5 | 32.5 ± 17.9 | 37.2 ± 18.4 |
2P value | P = 0.81 | P = 0.59 | P = 0.74 | P = 0.000 | P = 0.000 |
P value from the Mann Whitney U test;
P value from the Student’s t test.